King Teck Long, Tiong Lee Len, Kaman Zurainah, Zaw Win Moe, Abdul Aziz Zariah, Chung Law Wan
Pharmacy Department, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia; Clinical Research Centre, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia.
Clinical Research Centre, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia.
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105012. doi: 10.1016/j.jstrokecerebrovasdis.2020.105012. Epub 2020 Jun 18.
Located on the Borneo Island, Sarawak is the largest state of Malaysia and has a population distinctive from Peninsular Malaysia. The ischaemic stroke data in Sarawak had not been reported despite the growing number of patients annually. We aimed to investigate patient characteristics, management, and outcomes of ischaemic stroke in Sarawak and benchmark the results with national and international published data.
We included ischaemic stroke cases admitted to Sarawak General Hospital between June 2013 and August 2018 from Malaysia National Stroke Registry. We performed descriptive analyses on patient demographics, cardiovascular risk factors, prior medications, smoking status, arrival time, thrombolysis rate, Get With The Guidelines (GWTG)-Stroke measures, and outcomes at discharge. We also numerically compared the results from Sarawak with the published data from selected national and international cohorts.
We analysed 1435 ischaemic stroke cases. The mean age was 60.1±13.2 years old; 64.9% were male; median baseline National Institute of Health Stroke Scale was seven points. Hypertension was the most prevalent risk factor of ischaemic stroke; 12.7% had recurrent stroke; 13.7% were active smokers. The intravenous thrombolysis rate was 18.8%. We achieved 80-90% in three GWTG-Stroke performance measures and 90-98% in four additional quality measures in our ischaemic stroke management. At discharge, 57% had modified Rankin Scale of 0-2; 6.7% died during hospitalisation. When compared with selected national and international data, patients in Sarawak were the youngest; Sarawak had more male and more first-ever stroke. Thrombolysis rate in Sarawak was higher compared with most studies in the comparison. Functional outcome at discharge in Sarawak was better than national cohort but still lagging behind when compared with the developed countries. In-hospital mortality rate in Sarawak was slightly lower than the national data but higher when compared with other countries.
Our study described characteristics, management, and outcomes of ischaemic stroke in Sarawak. We achieved high compliance with most of GTWG-Stroke performance and quality indicators. Sarawak had better outcomes than the national results on ischaemic stroke. However, there is still room for improvement when compared with other countries. Actions are needed to reduce the cardiovascular burdens for stroke prevention, enhance healthcare resources for stroke care, and improve intravenous thrombolysis treatment in Sarawak.
砂拉越位于婆罗洲岛,是马来西亚最大的州,其人口与马来西亚半岛不同。尽管每年缺血性中风患者数量不断增加,但砂拉越的缺血性中风数据尚未报告。我们旨在调查砂拉越缺血性中风的患者特征、治疗及结局,并将结果与国内和国际已发表的数据进行对比。
我们纳入了2013年6月至2018年8月间从马来西亚国家中风登记处收治到砂拉越总医院的缺血性中风病例。我们对患者人口统计学、心血管危险因素、既往用药情况、吸烟状况、就诊时间、溶栓率、遵循《美国心脏协会中风治疗指南》(GWTG)-中风措施及出院结局进行了描述性分析。我们还对砂拉越的结果与选定的国内和国际队列的已发表数据进行了数值比较。
我们分析了1435例缺血性中风病例。平均年龄为60.1±13.2岁;64.9%为男性;基线国立卫生研究院卒中量表中位数为7分。高血压是缺血性中风最常见的危险因素;12.7%有复发性中风;13.7%为现吸烟者。静脉溶栓率为18.8%。在我们的缺血性中风管理中,三项GWTG-中风绩效指标达到了8~90%,另外四项质量指标达到了90~98%。出院时,57%的改良Rankin量表评分为0~2分;6.7%在住院期间死亡。与选定的国内和国际数据相比,砂拉越的患者最年轻;砂拉越男性更多,首次中风的患者更多。与大多数对比研究相比,砂拉越的溶栓率更高。砂拉越出院时的功能结局优于国内队列,但与发达国家相比仍有差距。砂拉越的住院死亡率略低于国内数据,但与其他国家相比更高。
我们的研究描述了砂拉越缺血性中风的特征、治疗及结局。我们在大多数GWTG-中风绩效和质量指标方面实现了高依从性。砂拉越在缺血性中风方面的结局优于国内结果。然而,与其他国家相比仍有改进空间。需要采取行动减轻中风预防的心血管负担,加强中风护理的医疗资源,并改善砂拉越的静脉溶栓治疗。